Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Ares Management to buy Singapore private equity firm Crescent Point Capital adding $3.8bn AuM
U.S-based alternative investment group Ares Management Corp has agreed to fully acquire Singapore-headquartered private equity firm Crescent Point Capital, according to a statement on Tuesday. “We believe that CPC is an excellent platform that will further enhance our...
Bowmark Capital Makes “Significant Investment” in Lending Powerhouse Lendscape With Over $200BN Lending Anually
Lending software provider Lendscape has received a “significant investment” from private equity firm Bowmark Capital, which will support the company’s expansion plans. Lendscape provides technology to more than 120 banks and financial institutions worldwide, to...
Carbon Underwriting Secures Significant Investment From PE Firm Apiary Capital
UK private equity firm Apiary Capital has completed a “significant strategic investment” in specialist independent managing general underwriter Carbon Underwriting Limited. Without disclosing the investment’s financial terms, Carbon chief executive Nick Tye said in a...